Profil Financier
Seo Jung-jin occupe actuellement le rang #455 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $8.4 B (-$447 sur 24h).
Seo Jung-jin is cofounder of Celltrion, a biopharmaceutical firm that makes drugs to treat cancer, influenza and rheumatoid arthritis, among others.
With the success of biosimilars in South Korea, his Celltrion has become a favorite among investors.
In 2023, Seo returned as chairman of his Celltrion group, two years after stepping down from the role, and pledged to make major acquisitions.
Seo's eldest son Jin-seok is cochairman of Celltrion Inc.
Seo started Celltrion Inc. in 2002 and took it public in 2008.
Seo is a former employee of Samsung Electro-Mechanics.